| Application no. and date | 17725086.7 (espacenet) (Federated) (European Patent Register), 20170511 | | Patent/reg. no. and date | DK/EP 3463469, 20231213 | | Publication date | 20190410 | | Priority no. and date | US 201662342787 P, 20160527 | | EP pub. no. and date |
EP 3463469 20190410 | | Effective date | | | Applicant/owner | Gilead Sciences, Inc., 333 Lakeside Drive
Foster City, CA 94404, US | | Applicant ref. no. | | | Inventor | GAGGAR, Anuj, c/o Gilead Sciences Inc.
333 Lakeside Drive
Foster City, CA 94404, US,
SUBRAMANIAN, G., Mani, c/o Gilead Sciences Inc.
333 Lakeside Drive
Foster City, CA 94404, US | | Representative | | | Opponent | | | IPC Class | A61K 31/454 (2006.01) , A61K 31/498 (2006.01) , A61K 31/675 (2006.01) , A61K 31/7072 (2006.01) , A61K 45/06 (2006.01) , A61P 31/14 (2006.01) | | Title | METHODS FOR TREATING HEPATITIS B VIRUS INFECTIONS USING NS5A, NS5B OR NS3 INHIBITORS | | Int. application no. | US2017032282 | | Int. publication no. | WO2017205078 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
